A consortium of laboratory and clinical investigators whose efforts are directed toward addressing research questions bearing on the etiology, pathogenesis, treatment and cure of type 1 and type 2 diabetes.
Study on computer-assisted diabetes risk management conducts research to improve quality of diabetes care and explores the effects of Accu-Chek Mellibase, in primary care.
Biopharmaceutical company established to develop new therapies that may prevent, ameliorate, or reverse diabetes and allow for the discontinuation of insulin.
Conducted research to find out more about the role that genes play in causing kidney disease in people with type 1 diabetes. Recruitment for this study closed November 2004.
Serves to inform people not only of the insulin resistance syndrome, but also of a physicians' congress on the topic. Includes congress information, past meetings, and publications.